High prevalence of the metabolic syndrome in hypertensive rural Chinese women

Acta Cardiologica

Volumn 63, Issue 5, 2008, Pages 591-598

  Zhang, Xingang ^a   Sun, Zhaoqing ^a   Zhang, Dayi ^b   Zheng, Liqiang ^a   Liu, Shuangshuang ^a   Xu, Changlu ^a   Li, Jiajin ^a   Li, Jue ^c   Hu, Dayi ^c   Sun, Yingxian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Department of Thoracic and Cardiovascular Surgery   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Epidemiology; Hypertension; Metabolic syndrome; Rural population; Women

Indexed keywords

CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESERPINE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MONGOLIA; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; RURAL AREA; SAMPLING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; RURAL POPULATION;

EID: 56049091524     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.5.2033226     Document Type: Article

References (46)

1. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999 (publ. no. WHO/NCD/NCS/99.2).
2. Alberti KGM, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059-62.
3. Bjorntorp P, Holm G, Rosmond R, Folkow B. Hypertension and the metabolic syndrome: closely related central origin? Blood Press 2000; 9: 71-82.
4. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004; 43: 1817-22.
5. Sun Z, Zheng L, Wei Y, Li J, Zhang X, Zhang X, Liu S, Xu C, Li J, Zhao F, Dong G, Hu D, Sun Y. The prevalence of prehypertension and hypertension among rural adults in Liaoning province of China. Clin Cardiol 2007; 30: 183-7.
6. Zhang X, Sun Z, Zheng L, Li J, Liu S, Xu C, Li J, Zhao F, Hu D, Sun Y. Prevalence of dyslipidemia and associated factors among the hypertensive Chinese rural population. Arch Med Res 2007; 38: 432-9.
7. Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J 2004; 25: 2183-4.
8. Katsouyanni K, Rimm EB, Gnardellis C, Trichopoulos D, Polychronopoulos E, Trichopoulou A. Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. Int J Epidemiol 1997; 26: S118-27.
9. Panagiotakos DB, Pitsavos C, Chrysohoou C, Risvas G, Kontogianni MD, Zampelas A, Stefanadis C. Epidemiology of overweight and obesity in a Greek adult population: the ATTICA Study. Obes Res 2004; 12: 1914-20.
10. Pajak A, Kuulasmaa K, Tuomilehto J. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project. World Health Stat Q 1988; 41: 115-40.
11. National Institute on Alcohol Abuse and Alcoholism: Health risks and benefits of alcohol consumption. Tenth Special Report to the US Congress on Alcohol and Health. Alcohol Res Health 2000; 24: 5-11.
12. Caballero B, Popkin BM. The Nutrition Transition: Diet and Disease in the Developing World. London: Academic Press, 2002.
13. Weng X, Liu Y, Ma J, Wang W, Yang G, Caballero B. An urban-rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr 2007; 10: 131-6.
14. Executive Summary: Demographic Profile of China [article online]. http://www.prcdc.org/summaries/china/china.html,2002.
15. Lasky D, Becerra E, Boto W, Otim M, Ntambi J. Obesity and gender differences in the risk of type 2 diabetes mellitus in Uganda. Nutrition 2002; 18: 417-21.
16. Catalano PM. Obesity and pregnancy - the propagation of a viscous cycle? J Clin Endocrinol Metab 2003; 88: 3505-6.
17. Kraja AT, Rao DC, Weder AB, Mosley TH, Turner ST, Hsiung CA, Quertermous T, Cooper R, Curb JD, Province MA. An evaluation of the metabolic syndrome in a large multiethnic study: the Family Blood Pressure Program. Nutr Metab (Lond) 2005; 2: 17.
18. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res 2005; 28: 27-34.
19. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-81.
20. Lu W, Liu MX, Li R, Fu H, Jin TY, Zhang SN. Epidemiological feature of metabolic syndrome in Shanghai residents aged 15-74 years. Zhonghua Yu Fang Yi Xue Za Zhi 2006; 40: 262-8 [in Chinese].
21. DECODA Study Group. Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Res Clin Pract 2007; 76: 57-67.
22. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28: 2745-9.
23. Bulhões K, Araújo L. Metabolic syndrome in hypertensive patients: correlation between anthropometric data and laboratory findings. Diabetes Care 2007; 30: 1624-6.
24. Kelishadi R, Derakhshan R, Sabet B, Sarraf-Zadegan N, Kahbazi M, Sadri GH, Tavasoli AA, Heidari S, Khosravi A, Amani A, Tolouei HR, Bahonar A, Rezaei Ashtiani AA, Moatarian A. The metabolic syndrome in hypertensive and normotensive subjects: the Isfahan Healthy Heart Programme. Ann Acad Med Singapore 2005; 34: 243-9.
25. DeFronzo R, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dylipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
26. Eriksson H, Welin L, Wilhelmsen L, Larsson B, Ohlson LO, Svardsudd K, Tibblin G. Metabolic disturbances in hypertension: results from the population study 'men born in 1913'. J Intern Med 1992; 232: 389-95.
27. Sadeghi M, Roohafza HR, Kelishadi R. Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme. Med J Malaysia 2004; 59: 460-7.
28. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-36.
29. Liu J, Hanley AJ, Young TK, Harris SB, Zinman B. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes (Lond) 2006; 30: 669-76.
30. Ford ES. Factor analysis and defining the metabolic syndrome. Ethn Dis 2003; 13: 429-37.
31. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004; 33: 28-36.
32. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, Gill T, Ruffin R. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 2005; 28: 2777-9.
33. Irwin ML, Ainsworth BE, Mayer-Davis EJ, Addy CL, Pate RR, Durstine JL. Physical activity and the metabolic syndrome in a tri-ethnic sample of women. Obes Res 2002; 10: 1030-7.
34. Liu S, Manson JE. Dietary carbohydrates, physical inactivity, obesity, and the 'metabolic syndrome' as predictors of coronary heart disease. Curr Opin Lipidol 2001; 12: 395-404.
35. Stewart KI. Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health. JAMA 2002; 288: 1622-31.
36. Pratley RE, Hagberg JM, Dengel DR, Rogus EM, Muller DC, Goldberg AP. Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulated insulin responses in middleaged and older men. J Am Geriatr Soc 2000; 48: 1055-61.
37. Pescatello LS, Murphy D, Costanzo D. Low-intensity physical activity benefits blood lipids and lipoproteins in older adults living at home. Age Ageing 2000; 29: 433-9.
38. Heim DL, Holcomb CA, Loughin TM. Exercise mitigates the association of abdominal obesity with high-density ]ipoprotein cholesterol in premenopausal women: results from the third National Health and Nutrition Examination Survey. J Am Diet Assoc 2000; 100: 1347-53.
39. Pekkanen J, Tuomilehto J, Uutela A, Vartiainen E, Nissinen A. Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ 1995; 311: 589-93.
40. Hoeymans N, Smit HA, Verkleij H, Kromhout D. Cardiovascular risk factors in relation to educational level in 36 000 men and women in The Netherlands. Eur Heart J 1996; 17: 518-25.
41. Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KG. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 1997; 40: 1341-9.
42. Brancati FL, Whelton PK, Kuller LH, Klag MJ. Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol 1996; 6: 67-73.
43. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003; 14: 15-9.
44. Warensjo E, Sundstrom J, Lind L, Vessby B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 2006; 84: 442-8.
45. Schachter M. Blood pressure reduction in the metabolic syndrome and type 2 diabetes: current concepts. Br J Diabetes Vasc Dis 2005; 5: 320-4.
46. Sierra C, Ruilope LM. New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial. J Renin Angiotensin Aldosterone Syst 2003; 4: 169-70.